TruAlt Bioenergy Limited has submitted a regulatory disclosure to BSE Limited and National Stock Exchange of India Limited regarding scheduled interactions with analysts and institutional investors. The disclosure is made in accordance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company's Managing Director, Mr. Vijaykumar Murugesh Nirani, and Chief Financial Officer, Mr. Anand Kishore, will be conducting one-to-one meetings with institutional investors from August 18, 2026 to August 20, 2026. The meetings will be held physically at the respective offices of the investors in Mumbai.
Participating institutional investors include: Abakkus MF, Bajaj Alternatives, Evision Capital, Invesco MF, Roha AMC, Singularity AMC, ValueQuest, and Tata MF.
The company explicitly states that the discussion during these meetings will be based solely on publicly available information, and no unpublished price-sensitive information will be shared.
The meetings are subject to last-minute changes due to exigencies on the part of either the investors or the company. The interactions will be moderated by a representative from InCred Research Services Private Limited.
This information is also available on the company's website at www.trualtbioenergy.com.